PTGS2 and atrial fibrillation: Focusing on the cellular consequences of complement activation in IVD cells, we found that stimulation with zymosan and HS enhanced the gene expression levels of the catabolic enzymes ADAMTS4 and MMP1 as well as those of the inflammation marker COX2 in AF cells, which were significantly reduced via complement inhibition using eculizumab.